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ABSTRACT
Introduction. Seizures are neurological emergencies with short- 
and long-term adverse effects in pre-term infants. They may present 
with or without abnormal movements (clinical versus subclinical). 
Thus, the true incidence of seizures may be under-reported. Current 
research indicates that most seizures occur in the first few days of life, 
are associated with intraventricular hemorrhage (IVH), and show 
low response to anticonvulsant drugs. The purpose of this study was 
to evaluate incidence, etiology, clinical antecedents, mortality, and 
response to treatment of seizures in extremely pre-term infants.
Methods.xThis is a retrospective cohort study of pre-term infants 
< 29 weeks gestation from January 2011 to December 2013. Pres-
ence or absence of seizure was the outcome. Data extraction included 
demographics, medications, co-morbidities, mortality, and details of 
seizures. A multivariable prediction model was developed to evaluate 
risk for seizures.
Results. Analysis included 269 pre-term infants. Incidence of EEG-
confirmed seizures was 40% (108/269); 49% were clinical and 51% 
were subclinical. Seizures occurred in 72% of infants ≤ 24 weeks, 57% 
of those 25-26 weeks, and 23% of those 27-28 weeks. Most seizures 
(85%) occurred after day eight of life. Mortality was 14% in those with 
seizures versus 5% in those without (p = 0.019). The model showed 
seizures were associated significantly with gestational age and medi-
cations, while controlling for sex, APGAR score, and co-morbidities, 
including IVH. At discharge, anticonvulsants were continued in 66% 
(72/108) of infants with seizures.
Conclusion. The incidence of seizures was highest in infants born 
most premature. Contrary to previous research, nearly two-thirds of 
pre-term infants with seizures did not have IVH or cystic periventric-
ular leukomalacia; apnea of prematurity was a common presentation 
of subclinical seizures; and the majority of treated infants responded 
to Phenobarbital. These findings need be explored in future research. 
Kans J Med 2020;13:134-142
INTRODUCTION
Any seizure occurring in a term or pre-term infant may indicate a 
neurological emergency demanding urgent diagnosis and manage-
ment.1 However, the definition and identification of seizures, especially 
in pre-term infants, is an area of ongoing controversy.2 Seizures are 
difficult to diagnose in pre-term infants because they may have unco-
ordinated movements unrelated to seizures, repetitive movements 
that may or may not indicate seizures, or subclinical seizures with no 
abnormal movements. 
Volpe outlined five main types of neonatal seizures: subtle 
(subclinical), tonic, clonic, myoclonic, and non-paroxysmal repetitive 
behaviors.3 Subclinical seizures may be the most difficult to detect 
because they imitate normal behaviors. Conversely, tonic, clonic, and 
myoclonic seizures are clinical seizures involving motor movements, 
presenting as rhythmic jerks or sustained contractions that are repeti-
tive and may last one to two minutes or longer.1
Hypoxic-ischemic encephalopathy in full term infants is respon-
sible for as much as 80% of all seizures in the first two days of life.1 
Davis et al.4 found an increased risk of clinical seizures in extremely 
low birth weight infants (birth weight 401-1000 grams) who had 
severe intra-ventricular hemorrhage (IVH), sepsis, meningitis, and/
or cystic periventricular leukomalacia (PVL). Research is ongoing to 
understand the various causes of seizures in pre-term infants.
Acutely, seizures (clinical/subclinical) in pre-term infants can 
result in significant decrease in oxygenation, bradycardia, apnea, and 
deterioration of cardiorespiratory status. Pre-term infants with sei-
zures are at significantly higher risk for mortality, and in the long-term 
are at risk for neuro-developmental impairment (cognitive, motor, 
language skills), moderate to severe cerebral palsy, and epilepsy.4,5  
The incidence of seizures in pre-term infants may vary widely 
and is dependent on the method used to diagnose. The incidence of 
clinical seizures in pre-term infants was 4 to 58% in studies without 
electroencephalogram (EEG) confirmation.6-9 It is difficult to diag-
nose seizures in infants based solely on clinical features without the 
aid of EEG.10 There is also a high frequency of electro-clinical dis-
sociation in infants with seizures, meaning that infants may not show 
abnormal clinical movements in the presence of seizures.11 Hence, 
there is a significant risk of under-diagnosis of seizures in pre-term 
infants without the use of EEG.
Clinicians and researchers have used one of three types of EEG 
to monitor and diagnose seizures in pre-term infants. These three 
include: conventional 21 channel EEG (with or without video), con-
tinuous video EEG (cEEG), and amplitude-integrated EEG (aEEG). 
While cEEG may be the preferred method (“gold standard”) for diag-
nosing neonatal seizures, there are significant practical barriers to 
implementation, such as availability of expensive equipment, tech-
nologists to do the test, and clinical neurophysiologists to interpret 
the EEG.12,13 
Results from EEG monitoring show variability in the incidence of 
seizures. For example, the incidence in pre-term infants using cEEG 
in the first 72 hours of life was 5%,14 while incidence with aEEG ranged 
from 20% to 48%.15-17 A recent study compared simultaneous use of 
conventional EEG and aEEG monitoring and found that aEEG had 
a low sensitivity (50%) and low specificity (46%), and misclassified 
some events as seizures.18 Moreover, aEEG might miss seizures that 
occur far from the electrodes or show false positive seizures due to 
artifacts.19 
With the increased survival for extremely pre-term infants, there 
is an increased number at risk for seizures. Given the difficulty of 
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diagnosis of seizures in this population, the true incidence of seizures 
may be under-reported. Therefore, the purpose of this study was 
to evaluate extremely pre-term infants (< 29 weeks gestation) and 
measure the incidence and risk of EEG confirmed seizures, retro-
spectively. Etiology, clinical antecedents, mortality, and response to 
treatment of seizures also were explored.
METHODS
A retrospective cohort study was conducted with pre-term infants 
< 29 weeks gestation who were admitted to the neonatal intensive 
care unit (NICU) between January 1, 2011 and December 31, 2013. 
The institutional review board at the Wichita Medical Research and 
Education Foundation approved the study. Figure 1 shows the patient 
flowchart. First, all infants admitted to the NICU were assessed for 
gestational age and the presence or absence of clinical seizures. 
Second, pre-term infants < 29 weeks gestation were identified for 
inclusion into the analyses. 
Suspected Seizures. Clinical seizure was suspected based on 
abnormal movements (tonic, clonic, myoclonic, or subtle tongue 
thrusting/cycling). In addition, seizures were suspected in infants 
with refractory apnea defined as apnea (without any abnormal move-
ments) persisting despite treatment with Caffeine (20 mg/kg loading 
and 10 mg/kg maintenance), appropriate respiratory support, and 
when other causes of apnea, such as sepsis, were ruled out. The 
outcome used for the analysis was a dichotomous variable that rep-
resented presence or absence of seizures confirmed by conventional 
EEG.
Figure 1. Participant flowchart. 
Diagnostic Criteria for Seizure Using Conventional EEG. 
Conventional electroencephalography (Nihon-Kohden, Tokyo, 
Japan) was performed in pre-term infants suspected to have seizures, 
using the 10/20 international system of electrode placement and the 
neonatal electrode montage and recording through 17 to 21 channels 
for 30 to 60 minutes. The conventional EEG diagnostic criteria for 
electrical seizures were rhythmic, repetitive, stereotypic waveforms 
with an evolution of morphologic features, amplitude, or electric field, 
lasting greater than 10 seconds with minimum amplitude of 2 µV.12 
Seizures also were diagnosed when the EEG was positive for multiple 
electrical seizures and/or focal/multifocal sharp wave discharges. In 
select cases, continuous EEG (cEEG) was performed for 24 hours. 
Amplitude-integrated EEG (aEEG) was not used in this study.
A pediatric neurologist (SS), with 25 years’ experience, interpreted 
the EEG studies (conventional and continuous). Repeat EEG was 
done at periodic intervals to diagnose resolution of seizures. 
Identifying Etiology of Seizures. To identify etiology of seizures, 
the patient history, examination, laboratory tests, and imaging studies 
were reviewed. Laboratory studies included serum electrolytes, sepsis 
workup, cerebrospinal fluid studies (bacterial and viral), acid-base 
analysis, and state newborn screen. Workup for metabolic disorder 
(serum ammonia, urine and serum organic acids, serum amino-acid 
analysis, lactate, and pyruvate levels) was done when indicated. To 
diagnose IVH, a cranial ultrasound study (Logic-S8, GE Ultrasound 
Korea, Ltd, Gyeonggi-do, Korea with a 10c probe) was done on day 
seven of life. Infants with IVH were monitored with repeat cranial 
ultrasound at periodic intervals to assess resolution or worsening, 
development of post-hemorrhagic hydrocephalus, and PVL. When 
close to discharge, infants underwent brain magnetic resonance 
imaging (GE 1.5-Tesla 5X or LX, Milwaukee, WI) to confirm pres-
ence or absence of PVL. 
Treatment of Seizures. Phenobarbital was used as the first line 
drug to treat seizures (20 mg/kg loading dose and 5 mg/kg mainte-
nance dose). If clinical seizures persisted, the dose of Phenobarbital 
was increased to attain serum level of ≥ 30. The following drugs were 
added to Phenobarbital, in sequence, if clinical seizures persisted: 
1) Fosphenytoin (20 mg/kg loading dose and 5 mg/kg maintenance 
dose); 2) Levetiracetam (20 mg/kg loading dose and 10 to 20 mg/
kg/dose every 12 hours, maintenance dose); and 3) Lorazepam was 
used to control breakthrough seizures. Anticonvulsants were reduced 
gradually and discontinued when a follow-up EEG confirmed resolu-
tion of seizures. 
Statistical Analysis. The primary outcome was presence or 
absence of seizure. Gestation, birth weight, and age at seizure diag-
nosis were evaluated for normality with the Kolmogorov-Smirnov 
test and summarized with medians, means, and standard deviations. 
Categorical data (sex, cesarean birth, medications, co-morbidities, 
procedures, and death) were summarized with frequencies and per-
centages. Where data were sparse, categories were collapsed. For 
example, gestation was grouped by < 24 weeks, 25-26 weeks, and 
27-28 weeks; birth weight was categorized as < 749 g, 750-999 g, and 
1000 g or more; Apgar scores were categorized as 0-3, 4-6, and 7+; 
age of seizure diagnosis was categorized as 0-7 days, 8-14 days, 15-21 
days, and 22+ days. Bivariable analyses by seizure outcome were con-
ducted: continuous data were evaluated with t-tests or with Mann 
Whitney U tests; categorical data were evaluated with Chi-square 
tests. Exact tests were used when data were sparse. Unadjusted preva-
lence ratios were calculated by seizure outcome for each variable. 
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understand risk for EEG confirmed seizures, a diagnostic, multivari-
able binomial regression model was developed using criteria from 
TRIPOD.20 Selection of independent variables for model inclusion 
were based on bivariable analysis results and factors that occurred 
in the early part of clinical course (prior to the diagnosis of seizure). 
To avoid the potential for model over- or under-fitting, the number 
of predictors was kept to a minimum; thus, those variables with fewer 
than 10 outcome events were not included in the model. General-
ized linear models utilizing the binomial distribution were conducted 
using a variety of linking functions. Collinearity was evaluated with 
correlation coefficients and Variance Inflation Factor (VIF). Crite-
rion for multicollinearity was mean VIF > 1. Model inclusion among 
the correlated predictor variables was based on clinical importance, 
strongest correlation to seizure, and VIF. Goodness of fit measures, 
such as Deviance and Akaike’s Information Criterion, were used 
to describe how well the model fit the observed values. Model cali-
bration was evaluated graphically using observed versus predicted 
values. Discrimination was determined by the concordance index 
(c-index). Internal validation of the final statistical model involved a 
bias correcting bootstrap technique with 5,000 samples. All statisti-
cal analyses were conducted in IBM SPSS Statistics for Windows, 
Version 23.0, Armonk, NY: IBM Corp.
RESULTS
Figure 1 shows all infants admitted to the NICU during the study 
period. The overall incidence of seizures was 9% (222 of 2,445). 
There were 269 infants born < 29 weeks gestation, and seizures in 
these infants accounted for more than 53% (119/222) of all seizures 
observed in the NICU. The proportion of seizures in pre-term infants 
was 44% (119/269) and 40% (108/269) with EEG confirmation. A 
downward, linear trend was observed between seizure and gestational 
age: for infants born at ≤ 24 weeks the incidence was 72% (39/54), for 
25-26 weeks it was 57% (49/85), and for those born at 27-28 weeks 
the incidence was 23% (31/130). 
Table 1 shows the bivariable results for characteristics of pre-term 
infants < 29 weeks gestation by outcome. Median gestation in weeks 
was significantly lower for those with seizures 25.0 versus 27.0 (p < 
001). The prevalence ratio (PR) of seizure (PR = 3.03) was signifi-
cantly higher for those born most premature at < 24 weeks gestation 
compared to those born at 27 to 28 weeks; p < 0.001. Likewise, preva-
lence ratio was greatest when birth weight was lowest: PR = 2.55 for 
those < 749 g compared with 1000+ g (p < 0.001).  Prevalence ratios 
were greatest for lower APGAR scores, 0-3, at one minute (PR = 1.89) 
compared with higher scores of 7+ (p = 0.015). Conversely, infants 
born via C-section were less likely to experience seizures (PR = 0.64; 
p = 0.002). In addition, infants with seizures received dopamine more 
often (33% vs. 6%; p < 0.001). Fewer infants with seizures received 
Furosemide (10% vs. 29%); however, this drug was given after red 
cell transfusions and later in the course of hospital stay. There was no 
difference in exposure to Caffeine between the groups, 99% vs. 96%.
Infants with IVH were 1.5 times more likely to have seizures com-
pared to those without (p = 0.003), with the greatest difference of 
proportion occurring when IVH was severe (i.e., Grade 3 to 4; 46% 
     SEIZURES IN PRE-TERM INFANTS
   continued.
versus 7%). PVL occurred more often in the seizure group compared 
to the non-seizure group (13% vs. 0.7%), though data were sparse 
(PVL was classified as cystic in 50% of cases; data not shown). Not 
shown in Table 1 are 46 infants with seizures and IVH, PVL, or both: 
IVH only = 30 infants; PVL only = 3 infants; IVH plus PVL = 13 
infants. Thus, 38.7% of all seizures were associated with IVH and/or 
PVL. The overall mortality for the cohort was 9% (25/269). Mortal-
ity was significantly higher in infants with seizures compared to those 
without seizures (14% vs. 5%, p = 0.019).
The median age when seizures were diagnosed was day 16 (0, 47; 
Table 2). All 119 infants with seizures received Phenobarbital. When 
clinical seizures persisted despite attainment of therapeutic levels of 
Phenobarbital, additional drugs were used. In all, 10 (8%) received 
Fosphenytoin, 14 (12%) Lorazepam, and 3 (2%) Levetiracetam. Phe-
nobarbital, as monotherapy, controlled seizures in 85% of infants 
(data not shown). At discharge, over 66% (72/108) of surviving 
infants with seizures continued to receive one or more anticonvul-
sant. Anticonvulsants were discontinued within two months after 
discharge in most of these infants (data not shown). 
Table 3 compares clinical versus subclinical seizures. Clinical sei-
zures occurred in 49% of infants (58/119) compared to 51% (61/119) 
with isolated subclinical seizures. Seizure type differed significantly 
by gestation and birth weight. Pre-term infants ≤ 24 weeks presented 
more often with clinical seizures than with subclinical seizures, 50% 
vs. 16%, respectively; while those born at 27 to 28 weeks presented 
more often with subclinical seizures, 38% vs. 14% (p < 0.001). Infants 
with birth weight < 749 grams were diagnosed more often with clinical 
seizures (65.5%), while those 1,000 grams or more were diagnosed 
with subclinical seizures (28% vs. 9%; p = 0.002). More infants with 
clinical seizures died compared to those with subclinical seizures (12 
vs. 5; p = 0.067). Infants with subclinical seizures were significantly 
more likely to continue anticonvulsants at discharge (72% vs. 48%; 
p = 0.009).
Two infants diagnosed with seizures and no evidence of meningi-
tis at the time of diagnosis of seizures developed meningitis later in 
their hospital course (one culture negative and one Escherichia Coli). 
Three infants in the non-seizure group were diagnosed with menin-
gitis (late onset Group B Streptococcus; data not shown). Neither 
group had any infant with viral encephalitis. There were no metabolic 
causes identified for seizures in this cohort (hypoglycemia, hypocal-
cemia, hypo- or hypernatremia, and inborn errors of metabolism). 
Results from the final multivariable, diagnostic model for pre-
dicting risk for seizure are shown in Table 4. Infants have less risk 
of seizures if born more mature (PRadj = 0.66, p < 0.001) and with 
exposure to morphine (PRadj = 0.55, p = 0.019). In other words, the 
earlier an infant was born, the more likely they were to have seizures; 
although, Morphine administered early may reduce the risk. Con-
versely, those who received Dopamine had a two-fold greater risk for 
seizure. Cesarean birth was associated significantly with less seizure 
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in the bivariable analysis (p = 0.002; see Table 1). However, when taking 
all other factors into consideration, the multivariable results showed 
that cesarean birth was not associated significantly with seizures (p = 
0.071).
Performance measures of the final model were not optimal; AIC 
= 245.25, c-index = 0.789, correct classification = 73.6%, with sensi-
tivity = 61% and specificity < 16%. These results may be due to the 
overall sample size being small. However, to account for potential 
overfitting or uncertainty brought about by the sample size, a bias 
correcting bootstrap technique was conducted to quantify optimism 
of the model. For example, with regards to weeks gestation, the bias 
corrected 95% confidence interval for the adjusted prevalence of sei-
zures indicated that as gestation increased, the prevalence ratio for 
seizures decreased to between 0.60 and 0.70. The line for predict-
ing seizures formed a downward trend such that for every one unit 
increase in gestational age, the line dropped between 0.33 to 0.57 
units. Thus, gestation was associated inversely with the incidence of 
seizures. A similar interpretation can be made for morphine.
DISCUSSION
In this study, the incidence of conventional EEG-confirmed sei-
zures in extremely pre-term infants was 40%. Compared to the 
results from our study, Pisani et al.21, using conventional EEG but 
with video, reported that the incidence of seizures was 5.49% for 
pre-term infants 28 to 30 weeks and 8.56% for those less than 28 
weeks gestation. The results from our study were similar to the 48% 
incidence shown by Vesoulis et al.2 who used a two-channel ampli-
tude-integrated EEG (aEEG) to monitor for seizures. As shown by 
previous research, incidence of seizures in pre-term infants is depen-
dent on method of diagnosis. In addition, the incidence of seizures 
was high as we evaluated infants with refractory apnea extensively, 
which may not have been done in other studies.
With regards to timing of seizures, the mean age of diagnosis was 
17.9 days (range: 0-47 days, median was day 16). This is similar to 
the study by Pisani et al.22 who found a mean seizure onset of 14.6 
days (range: 1-120 days) in pre-term infants < 29 weeks and 5.2 days 
(range: 1-37 days) in those > 29 weeks gestation. Other studies have 
evaluated for seizures in the first 72 hours of life,14 whereas we evalu-
ated infants throughout the hospital stay, much longer evaluation 
period compared to other studies.
Table 1. Characteristics of pre-term infants < 29 weeks gestation by presence or absence of seizure. 
Seizure No seizure
Description, f % n = 119 44.2% n = 150 55.8% PRunadj* P
Demographics at birth
Male 54 45.4 75 50.0 0.9 0.451
Median gestation, weeks; mean (sd) 25.0; 25.4 (1.5) 27.0; 26.6 (1.4) -- < 0.001
Gestation (weeks)
≤ 24 39 32.8 15 10.0 3.03 < 0.001
25 to 26 49 41.2 36 24.0 2.42
27 to 28 31 26.1 99 66.0 Ref
Median birth weight (g); mean (sd) 740.0; 793.8 (228.2) 959.5; 957.3 (242.6) < 0.001
Birth weight (g) < 0.001
≤ 749 60 50.4 32 21.3 2.55
750 to 999 37 31.1 54 36.0 1.59
1000+ 22 18.5 64 42.7 Ref
Cesarean birth 78 65.5 123 82.0 0.64 0.002
APGAR score at 1 minute 0.015
A1: 0-3 55 46.2 51 34.0 1.89
A1: 4-6 50 42.0 62 41.3 1.63
A1: 7+ 14 11.8 37 24.7 Ref
APGAR at 5 minutes 0.063
A5: 0-3 18 15.1 12 8.0 1.53
A5: 4-6 36 30.3 37 24.7 1.26
A5: 7+ 65 54.6 101 67.3 Ref
Positive pressure ventilation 119 100.0 149 99.3 -- 0.999
Chest compressions 14 11.8 7 4.7 1.58 0.031
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Table 1. Characteristics of pre-term infants < 29 weeks gestation by presence or absence of seizure. cont.
Seizure No seizure
Description, f % n = 119 44.2% n = 150 55.8% PRunadj* P
Demographics at birth
Medications
Caffeinea 118 99.2 144 96.0 3.15 0.106
Dopaminea 39 32.8 9 6.0 2.25 < 0.001
Furosemide 12 10.1 44 29.3 0.43 < 0.001
Indomethacina 97 81.5 111 74.0 1.29 0.144
Gentamicin 64 53.8 84 56.0 0.95 0.196
Morphinea 33 27.7 38 25.3 1.07 0.658
Piperacillin-Tazobactama 107 89.9 142 94.7 0.72 0.140
Co-morbidities
Bronchopulmonary dysplasiab 104 87.4 84 56.0 2.99 < 0.001
Hydrocephalus (post-hemorrhagic) 10 8.4 0 0.0 -- < 0.001
Necrotizing enterocolitis 29 24.4 11 7.3 1.85 < 0.001
Patent ductus arteriosus 69 58.5 69 48.3 1.26 < 0.001
Retinopathy of prematurityc 62 52.1 35 25.2 1.81 0.008
Intraventricular hemorrhage (IVH)  43** 36.1 30 20.0 1.52 0.003
Grade 1 to 2 23 53.5 28 93.3 -- < 0.001
Grade 3 to 4 20 46.5 2 6.7 --
Periventricular leukomalacia (PVL)  16** 13.4 1 0.7 -- < 0.001
Surgeryd 45 37.8 16 10.7 2.07 < 0.001
Ventriculoperitoneal shunting 6 5.0 0 0.0 -- 0.005
Deathe 17 14.3 8 5.3 1.82 0.019
Frequencies and percentages are reported unless otherwise stated.
*PRunadj: Unadjusted prevalence ratio.
**Infants with IVH only = 30; PVL only = 3; IVH plus PVL = 13; thus, 38.7% of seizures were associated with IVH and/or PVL.
aMedications before the onset of seizures in seizures group.
bBronchopulmonary dysplasia: defined as need for oxygen and/or mechanical ventilation at day of life 28.
cSevere ROP treated with Avastin: 17 infants in the seizures group versus 3 infants in the no seizure group.
dSurgery for necrotizing enterocolitis, inguinal hernia repair, patent ductus arteriosus ligation.
eOf the 17 infants with seizures who died, 11 died before EEG confirmation. 
Table 2. Seizure characteristics of pre-term infants < 29 weeks gestation. 
EEG confirmed No EEG*
Description N = 108 90.8% N = 11 9.2%
Median age in days when seizure was diagnosed (min, max) 16.0 (0, 47) 7.0 (0, 18)
Age in days when seizure was diagnosed
Day 0 to 7 16 14.8 6 54.5
Day 8 to 14 28 25.9 2 18.2
Day 15 to 21 27 25.0 3 27.3
Day 22+ 37 34.3 0 0.0
Seizure type
Subclinical 61 56.5 0 0.0
Clinical (tonic/clonic) 47 43.5 11 100.0
Medications administered during hospital stay
Phenobarbital 108 100.0 11 100.0
Fosphenytoin 7 6.5 3 27.3
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Table 2. Seizure characteristics of pre-term infants < 29 weeks gestation. cont.
EEG confirmed No EEG*
Description N = 108 90.8% N = 11 9.2%
Lorazepam (Ativan) 10 9.3 4 36.4
Levetiracetam (Keppra) 1 0.9 2 18.2
Anticonvulsant at discharge 72 66.7 N/A --
*Infants who died before EEG confirmation of seizure.
Table 3. Comparing clinical versus subclinical seizures in pre-term infants < 29 weeks gestation.
Clinical* Subclinical
Description n=58 48.7% n=61 51.3% P
Baby’s sex
Female 32 55.2 33 54.1 0.999
Male 26 44.8 28 45.9
Gestation (weeks) < 0.001
<= 24 29 50.0 10 16.4
25 to 26 21 36.2 28 45.9
27 to 28 8 13.8 23 37.7
Birth weight (g) 0.002
<= 749 38 65.5 22 36.1
750 to 999 15 25.9 22 36.1
1000+ 5 8.6 17 27.9
Intraventricular hemorrhage 23 39.7 20 32.8 0.851
Grade 1 to 2 12 52.2 11 55.0 0.999
Grade 3 to 4 11 47.8 9 45.0
Periventricular leukomalacia 9 15.5 7 11.5 0.596
Death 12 20.7 5 8.2 0.067
Age in days when seizure was diagnosed 0.002
day 0 to 7 18 31.0 4 6.6
day 8 to 14 16 27.6 14 23.0
day 15 to 21 11 19.0 19 31.1
day 22+ 13 22.4 24 39.3
Anticonvulsants administered during hospital stay
Phenobarbital 58 100.0 61 100.0 --
Fosphenytoin 7 12.1 3 4.9 0.197
Ativan 9 15.5 5 8.2 0.262
Keppra 3 5.2 0 0.0 0.113
Anticonvulsant at discharge 28 48.3 44 72.1 0.009
*Clinical seizures included tonic, clonic, myoclonic seizures.
Table 4. Multivariable diagnostic model for predicting EEG confirmed seizures from clinical antecedents.
Bca* 95% CI of B Bca 95% CI of PRadj
Clinical antecedent n = 261* B Lower Upper VIF P PRadj Lower Upper
Male 125 -0.13 -0.60 0.26 1.02 0.519 0.88 0.50 1.30
Gestation of baby (weeks) 261 -0.41 -0.57 -0.33 1.53 < 0.001 0.66 0.60 0.70
Cesarean birth 196 -0.42 -0.94 0.11 1.13 0.071 0.65 0.40 1.10
APGAR score at 1 minute 1.23
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Table 4. Multivariable diagnostic model for predicting EEG confirmed seizures from clinical antecedents. cont.
Bca* 95% CI of B Bca 95% CI of PRadj
Clinical antecedent n = 261* B Lower Upper VIF P PRadj Lower Upper
A1: 0-3 99 0.15 -0.61 0.97 -- 0.659 1.16 0.50 2.60
A1: 4-6 111 0.47 -0.28 1.40 -- 0.139 1.60 0.80 4.10
A1: 7+ 51 ref -- -- -- -- -- -- --
Medications
Dopamine 48 0.86 0.23 1.85 1.28 0.001 2.37 1.30 6.30
Morphine 69 -0.60 -1.21 -0.10 1.11 0.019 0.55 0.30 0.90
Piperacillin-Tazobactam 241 -0.49 -1.48 0.20 1.05 0.175 0.61 0.20 1.20
Co-morbidities
Patent ductus arteriosus 138 0.30 -0.20 0.90 1.08 0.178 1.35 0.80 2.40
Intraventricular hemorrhage 72 0.18 -0.40 0.85 1.17 0.440 1.20 0.70 2.30
*BCa: Bias-corrected and accelerated with sample size of 5,000
Generalized Linear Model: Binomial probability distribution, Complementary log-log link function
**Eight infants were not included in the model due to missing data: 7 with no seizures who died within 2 days and 1 who had an EEG confirmed seizure.
Model assessment: Overall percentage correctly classified: 73.6%; Concordance Index C: 0.789
Omnibus test: Likelihood ratio: 82.87, df=10, p<0.001
Goodness of Fit: Deviance: 1.127; df=177; Pearson Chi-Square: 1.046; df-177; AIC: 254.25 
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Our results showed that the incidence of subclinical seizures was 
higher than reported in other studies (51% vs. 5%-23%).14,23 This dif-
ference was not surprising when you consider that these infants were 
more mature, had higher birth weight, and were diagnosed signifi-
cantly later than those with clinical seizures. Therefore, these infants 
might not have been suspected for seizures in other studies. This 
higher incidence of subclinical seizures in our study may be due to 
extensive use of EEG as part of the evaluation for infants with refrac-
tory apnea. 
Findings from animal models might explain the association of 
subclinical seizures with refractory apnea. The neurons in the re-
spiratory rhythmogenesis center (pre-Botzinger nucleus) show high 
expression of GABA receptor α-3 (depolarizing, excitatory) and low 
expression of α-1 (hyper-polarizing, inhibitory) subunits with high 
neuronal chloride.24 In addition, there is expression of Adenosine re-
ceptors (A2A) in the neurons that express GABA in the respiratory 
centers in brain stem. Activation of GABA receptor α-3 stimulates 
Adenosine receptor A2A to inhibit breathing.25 From these animal 
models, we can infer that initiation of seizures leads to apnea in pre-
mature infants and these were the infants diagnosed with subclinical 
seizures in our study. Regardless, infants with subclinical seizures 
were more likely to continue with an anticonvulsant at discharge. 
As electrographic (subclinical) seizures may be associated with dis-
turbed cerebral metabolism, prompt detection and treatment of sub-
clinical seizures may decrease the risk of later epilepsy.26
The results of our study showed that when infants are more pre-
mature (gestational age < 24 weeks), the incidence of seizure in-
creases. This higher incidence of seizures in extremely pre-mature 
infants is physiologically possible due to Gamma Amino Butyric 
Acid (GABA) exerting a paradoxical depolarization of immature 
cortical neurons. The depolarizing action of GABA in the immature 
brain is due to a high intracellular chloride concentration, mediated 
by chloride co-transporters NKCC1 (importer) and KCC2 (export-
er). However, these developmental changes only have been shown in 
animal models.27
With regards to etiology of seizures, our results showed a signifi-
cantly lower incidence of IVH and/or PVL compared Scher et al.28 
(39% vs. 90%). In addition, there were no other identifiable causes 
(metabolic/infection) in 61% of infants with seizures. In contrast, 
other studies have found that in addition to brain injury there were 
transient metabolic disorders (9.2%) and infection (3.9%) causing 
seizures in pre-term infants.22 However, seizures of genetic origin,29 
such as variants in ion channels (SCN1A, SCN2A, KCNQ2), were 
not investigated in this study.
While bivariable results showed a significant association between 
cesarean birth and decreased risk of seizures, the multivariable anal-
ysis conducted did not demonstrate this (probably due to the small 
sample size). There is, however, evidence from previous research 
showing that cesarean birth is associated with decreased risk of 
IVH.30,31 It may be that cesarean birth is associated with decreased 
risk of seizure due to less risk of IVH, but this needs to be evaluated 
in future studies.
We found that early use of morphine decreased risk of seizures 
in pre-mature infants. In some animal models, morphine has been 
shown to have anti-convulsant effects via the nitric acid pathway.32 
Whether this mechanism is important in pre-term infants is not 
clear.
Conversely, dopamine administered to pre-mature infants was as-
sociated with an increased risk of seizures. Dopamine may be a sur-
rogate marker for severity of illness. Indeed, close inspection of the 
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data revealed that infants who had seizures and received dopamine 
had: 1) lower APGAR scores at one minute, 2) were born at earlier 
gestation, 3) weighed less, and 4) had higher incidence of hydroceph-
alus or PVL. All infants with seizures, both clinical and subclinical, 
were treated with anticonvulsants in our study. Others, however, 
have used phenobarbital selectively for subclinical seizures.17 In our 
cohort, Phenobarbital monotherapy controlled seizures in most 
(85%) infants. In other studies, complete response to Phenobarbital 
was observed in 62%, partial response in 16.5%, and no response in 
20.9%.33 There is concern that Phenobarbital can cause apoptotic 
neuro-degeneration in the developing brain, as shown in animal 
models.34 However, Shankaran et al.35 showed that antenatal exposure 
to Phenobarbital did not adversely affect the neuro-developmental 
outcome of pre-mature infants at 18 to 22 months of age. More recent 
data, from animal studies, have shown that Caffeine administered 
with Phenobarbital decreased the negative effects of Phenobarbital 
on neural cells.36 In our study, nearly all infants with seizures treated 
with Phenobarbital were receiving Caffeine for apnea of prematurity. 
The limitations of this study were the small sample size that origi-
nated from a single center, which may reduce generalizability, along 
with the retrospective design with little data on long-term neuro-
developmental outcome. The strengths of this study were that all 
suspected seizures were confirmed with conventional EEG, the 
detailed workup to detect underlying etiology, seizure treatment per 
protocol, and adherence to TRIPOD for the model building process.
CONCLUSIONS
The incidence of neonatal seizures was high in pre-term infants 
< 29 weeks, most likely due to conventional EEG confirmation and 
inclusion of those with subclinical seizures. Significant number of 
infants with refractory apnea had subclinical seizures, which has not 
been highlighted before. The multivariable predictive model showed 
that extreme prematurity and dopamine increased the risk of sei-
zures, while early exposure to morphine decreased the risk. There 
were no detectable brain lesions (IVH/PVL) in 61% of infants with 
seizures; this finding challenges the dogma that most seizures in 
pre-term infants are due to IVH or PVL or central nervous system 
infection. In addition, the response to Phenobarbital was higher than 
previously reported. Whether prompt detection and treatment of 
seizures (both clinical and subclinical) in extremely pre-term infants 
would improve long-term neuro-developmental outcome needs 
urgent study. A study of this nature could benefit from close co-oper-
ation between neonatologists and neurologists.
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